May 17, 2022, 12:00 PM
Online

Register for this Event

Online Viewing

In light of the COVID-19 pandemic, this panel discussion will be held virtually, as an online webinar. The event will be recorded, captioned, and distributed at a later date for registrants who are unable to watch live. To ensure that you receive access to the livestream and the recording, register now. We will send out a link to the livestream of the event to all registrants the day before and day of the event. Last registration is 11:30am on the day of the event.

Event Description

Advances in the scientific understanding of addiction have important implications for treatment, policy, and the law. In this panel, Eden Evins, M.D. will discuss addiction neuroscience, prognosis, and treatment. Stephanie Tabashneck, Psy.D., J.D. will then lead a discussion on the role of addiction science in judicial and legal decision making at the intersection of science and the law.

Join the conversation or submit questions on Twitter @PetrieFlom using #LawAndNeuro.

Panelists

• Introduction: Carmel Shachar, Executive Director, Petrie-Flom Center
• Eden Evins, M.D., Director, MGH Center for Addiction Medicine and Cox Family Professor of Psychiatry, Harvard Medical School
• Stephanie Tabashneck, PsyD, JD, Senior Fellow in Law and Applied Neuroscience, CLBB and the Petrie-Flom Center

In Fall 2021, law students at Northeastern University School of Law (NUSL) under the direction of Professor Stevie Leahy began investigation into the current state of law and public policy regarding the sentencing of juvenile offenders across the United States.  This investigation was prompted by the Spring 2021 decision by the US Supreme Court in Jones v. Mississippi. Many experts consider Jones to signal the end of increasing 8^th Amendment protections for juveniles under a series of cases since 2005. In its wake, Jones will now leave the requirements of juvenile sentencing to the discretion of individual courts and/or legislatures. The NUSL students (known as Law Office 7) completed this project in March 2022 and released their analysis and recommendations as Juvenile (in) Justice: The Role of Science and Advocacy in Juvenile Justice Post-Jones.  CLBB served as a partner organization for this project, which coincided with their publication of a detailed whitepaper aligning scientific research with prior factors considered by courts in juvenile sentencing. CLBB Executive Director Dr. Robert Kinscherff and Affiliated Faculty Judge Jay Blitzman (ret.) consulted with the students, with Judge Blitzman bringing his nationally recognized expertise in this area.  Armand Coleman, Executive Director at the Transformational Prison Project, also provided his guidance and expertise to the students. The research by Law Office 7 confirms that a lack of clarity and specific requirements within juvenile sentencing decisions increases disparities in “justice by geography” when it comes to sentencing outcomes.

Please click here to view the guide: https://drive.google.com/file/d/1KOf3pFJ7ANmT8o47xPowW65vJrejuTxo/view?usp=sharing

 April 20, 2022, 12:00 PM
 Online

WATCH RECORDING HERE

Event Description

The legalization of cannabis has raised significant questions for law and public policy. In this public event, neuroscientist Dr. Yasmin Hurd will explore the science of cannabis, CBD, and the future of substance use disorder treatment. Dr. Stephanie Tabashneck will then moderate a discussion and audience Q&A about the implications for law and policy.

Join the conversation or submit questions on Twitter @PetrieFlom using #LawAndNeuro.

Panelists

• Introduction: Carmel Shachar, Executive Director, Petrie-Flom Center
• Yasmin Hurd, PhD, Ward-Coleman Chair, Translational Neuroscience, Professor Psychiatry and Neuroscience, and Director, Addiction Institute, Icahn School of Medicine at Mount Sinai
• Stephanie Tabashneck, PsyD, JD, Senior Fellow in Law and Applied Neuroscience, CLBB and the Petrie-Flom Center

This event is part of the Project on Law and Applied Neuroscience, a collaboration between the Center for Law, Brain and Behavior at Massachusetts General Hospital and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.

April 20, 2022, 12:00 PM
Online

 Register for this Event

Online Viewing

In light of the COVID-19 pandemic, this panel discussion will be held virtually, as an online webinar. The event will be recorded, captioned, and distributed at a later date for registrants who are unable to watch live. To ensure that you receive access to the livestream and the recording, register now. We will send out a link to the livestream of the event to all registrants the day before and day of the event. Last registration is 11:30am on the day of the event.

Event Description

The legalization of cannabis has raised significant questions for law and public policy. In this public event, neuroscientist Dr. Yasmin Hurd will explore the science of cannabis, CBD, and the future of substance use disorder treatment. Dr. Stephanie Tabashneck will then moderate a discussion and audience Q&A about the implications for law and policy.

Join the conversation or submit questions on Twitter @PetrieFlom using #LawAndNeuro.

Panelists

• Introduction: Carmel Shachar, Executive Director, Petrie-Flom Center
• Yasmin Hurd, PhD, Ward-Coleman Chair, Translational Neuroscience, Professor Psychiatry and Neuroscience, and Director, Addiction Institute, Icahn School of Medicine at Mount Sinai
• Stephanie Tabashneck, PsyD, JD, Senior Fellow in Law and Applied Neuroscience, CLBB and the Petrie-Flom Center

This event is part of the Project on Law and Applied Neuroscience, a collaboration between the Center for Law, Brain and Behavior at Massachusetts General Hospital and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.

 March 31, 2022, 12:00 PM

View Recording Here

Event Description

In Commonwealth v. Eldred, the Massachusetts Supreme Judicial Court held that a court may order a defendant who is addicted to substances to remain drug free as a condition of probation and that if a defendant tests positive for an illegal substance, the defendant may be found in violation of his or her probation. Join us for a discussion of this important case. Attorney Lisa Newman-Polk, who litigated Eldred, will discuss the legal landscape regarding criminalization of addiction. Dr. Alexander Walley will contextualize substance use disorder as a medical illness. Dr. Stephanie Tabashneck will then lead a discussion on the implications of criminalizing substance use disorder.

Panelists

• Introduction: Carmel Shachar, Executive Director, Petrie-Flom Center
• Lisa Newman-Polk, lawyer and licensed certified social worker
• Alexander Walley,  Professor of Medicine, Boston University School of Medicine; Director, Addiction Medicine Fellowship Program; Co-Director, Fellow Immersion Training Program in Addiction Medicine; Associate Director, Faster Paths to Treatment Addiction Urgent Care Clinic; and Medical Director, Opioid Overdose Prevention Pilot Program, Massachusetts Department of Public Health
• Stephanie Tabashneck, PsyD, JD, Senior Fellow in Law and Applied Neuroscience, CLBB and the Petrie-Flom Center

This event is part of the Project on Law and Applied Neuroscience, a collaboration between the Center for Law, Brain and Behavior at Massachusetts General Hospital and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.